WebbThis page provides the clinical criteria documents for all injectable, infused, or implanted prescription drugs and therapies covered under the medical benefit. The effective dates … WebbThis page provides the clinical criteria documents for all injectable, infused, or implanted prescription drugs and therapies covered under the medical benefit.The effective dates … Advantage Network (Includes Retail 90 and Rx Maintenance 90) Available as … The Food and Drug Administration (FDA) is restricting the use of Ocaliva® … Site Map - Clinical Criteria - Anthem HoN Code - Clinical Criteria - Anthem Privacy - Clinical Criteria - Anthem About Us - Clinical Criteria - Anthem
Clinical Criteria updates
Webb11 apr. 2024 · 100. Subcategory: D-Sub Connectors. Part # Aliases: 020419-0018. Unit Weight: 0.081106 oz. Select at least one checkbox above to show similar products in … Webb3/18/2024 ING-CC-0019* Zoledronic Acid Agents Revised 3/18/2024 ING-CC-0022 Vimizim (elosulfase alfa) Revised 3/18/2024 ING-CC-0023 Naglazyme (galsulfase) Revised 3/18/2024 ING-CC-0031* Intravitreal Corticosteroid Implants Revised . Page 2 of 3 Effective date Document number Clinical ... boxes short form
Provider Communications
WebbAugust 30, 2024 ING-CC-0019* Zoledronic Acid Agents (Reclast, Zometa) Revised August 30, 2024 ING-CC-0027* Denosumab Agents Revised August 30, 2024 ING-CC-0028* Benlysta (belimumab) Revised August 30, 2024 ING-CC-0031 Intravitreal Corticosteroid Implants Revised August 30, 2024 ING-CC-0032* Botulinum Toxin Revised WebbThis page provides the clinical criteria documents for all injectable, infused, or implanted prescription drugs and therapies covered under the medical benefit. The effective dates for using these documents for clinical reviews are communicated through the Provider notification process. The clinical criteria information is alphabetized in the ... Webb23 jan. 2024 · Please note, this communication applies to Healthy Blue + MedicareSM (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina (Blue Cross NC). Summary: On August 19, 2024, and September 9, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug … gun wound treatment